Neuroimaging biomarkers in bipolar disorder

Josselin Houenou1, Marc-Antoine d'Albis, Francois-Eric Vederine

  • 1AP-HP, University Paris-East, Department of Psychiatry, Henri Mondor-Albert Chenevier Hospitals, Creteil, F-94010, France. josselin.houenou@inserm.fr

Summary

Objective biomarkers are needed for bipolar disorder (BD) assessment. Neuroimaging reveals cortical-limbic dysregulation in BD, with reduced dorsal brain activity and altered prefrontal-subcortical limbic connectivity, offering potential diagnostic insights.

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.